c-Myc tag Peptide: Precision Reagent for Immunoassay and Cancer Research

Executive Summary: The c-Myc tag Peptide (SKU: A6003, APExBIO) is a synthetic peptide corresponding to human c-Myc residues 410–419, enabling specific displacement of c-Myc-tagged fusion proteins in immunoassays (APExBIO product page). It demonstrates high solubility in DMSO (≥60.17 mg/mL) and water (≥15.7 mg/mL with sonication) but is insoluble in ethanol, aiding experimental flexibility. The c-Myc tag sequence facilitates robust anti-c-Myc antibody inhibition, streamlining workflows in transcription factor and proto-oncogene research. c-Myc protein is a pivotal transcription factor regulating proliferation, apoptosis, and differentiation, with well-documented proto-oncogenic roles in cancer biology (Wu et al., 2021). This article details the biological rationale, mechanism, benchmarks, and practical integration of the c-Myc tag Peptide for advanced cancer research.

Biological Rationale

The c-Myc protein is a transcription factor encoded by the MYC proto-oncogene in humans. It is involved in regulating cell proliferation, growth, apoptosis, differentiation, and stem cell maintenance (Wu et al., 2021). Overexpression or gene amplification of c-Myc is frequently observed in diverse human cancers, including Burkitt lymphoma, breast carcinoma, and colorectal cancer. c-Myc directly upregulates cyclin genes and ribosomal biogenesis, while repressing cell cycle inhibitors such as p21 and anti-apoptotic factors like Bcl-2. The C-terminal 410–419 amino acid sequence of c-Myc is widely used as an epitope tag (myc tag) in recombinant protein studies due to its high immunogenicity and minimal interference with protein function. The synthetic c-Myc tag Peptide (A6003) mimics this sequence, providing a competitive reagent for precise immunoassay modulation and fusion protein detection (APExBIO).

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide operates by competitive inhibition. It binds to anti-c-Myc antibodies, effectively displacing c-Myc-tagged fusion proteins from immune complexes. This displacement enables elution of target proteins and minimizes background in immunoprecipitation (IP), Western blot, and ELISA platforms. The peptide's defined sequence (EQKLISEEDL) ensures specificity, reducing off-target effects. In transcription factor studies, c-Myc tagging allows researchers to track, isolate, and quantify fusion protein dynamics. The peptide is stable when stored desiccated at −20°C and should not be kept in solution for prolonged periods to prevent degradation (APExBIO).

Evidence & Benchmarks

• The c-Myc tag Peptide supports displacement of c-Myc-tagged fusion proteins from anti-c-Myc antibody complexes in standard immunoassays, improving signal-to-noise (APExBIO, product documentation).
• High solubility is documented at ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water with ultrasonication, but the peptide is insoluble in ethanol (APExBIO, product page).
• The c-Myc tag sequence is widely recognized and used in fusion protein detection; its immunogenicity has been validated across multiple host species (c-myc-peptide.com).
• c-Myc regulates cell proliferation and apoptosis by upregulating cyclins and repressing p21 and Bcl-2, directly impacting oncogenesis (Wu et al., 2021).
• Selective autophagy modulates transcription factor stability (e.g., IRF3), suggesting broader implications for tagged transcription factors in immune and cancer biology (Wu et al., 2021).

Applications, Limits & Misconceptions

The c-Myc tag Peptide is primarily employed for:

• Displacing c-Myc-tagged fusion proteins from anti-c-Myc antibodies in immunoprecipitation and ELISA assays.
• Blocking anti-c-Myc antibody binding to reduce background in Western blotting.
• Serving as a negative control in immunodetection experiments to confirm specificity.
• Enabling functional studies of transcription factors and proto-oncogenes in cancer models.

For detailed troubleshooting and case studies on advanced immunoassay disruption, see c-Myc Tag Peptide: Driving Next-Generation Cancer Biology, which this article extends by providing atomic, quantitative performance data and clarifying solubility constraints.

Common Pitfalls or Misconceptions

• The c-Myc tag Peptide does not serve as an antibody itself; it is a competitive inhibitor for anti-c-Myc antibodies.
• It is not suitable for in vivo therapeutic use or diagnostic purposes; intended for research use only (APExBIO).
• The peptide is insoluble in ethanol; attempts to dissolve it in ethanol will result in precipitation and loss of activity.
• Long-term storage of peptide solutions leads to degradation; only reconstitute immediately before use.
• It does not alter endogenous c-Myc protein function in cells when added exogenously; its effects are limited to immunoassay displacement.

Read more about innovative transcription factor applications in c-Myc tag Peptide: Innovations in Transcription Factor, which this article updates with solubility and competitive inhibition benchmarks.

Workflow Integration & Parameters

The c-Myc tag Peptide is supplied as a lyophilized powder. For optimal use:

• Reconstitute in DMSO (≥60.17 mg/mL) or water (≥15.7 mg/mL, sonication advised).
• Store stock powder desiccated at −20°C; avoid repeated freeze-thaw cycles.
• Prepare working solutions freshly; do not store solutions long-term.
• Typical working concentrations for immunoassay displacement: 1–10 μg/mL; titrate per assay requirements.
• Confirm displacement efficacy by reduction in target signal after peptide addition in IP or Western blot.

For practical integration strategies in advanced workflows, see c-Myc tag Peptide: Next-Generation Tools for Transcription, and note that this article provides an updated summary of physical parameters and storage guidelines.

Conclusion & Outlook

The c-Myc tag Peptide (APExBIO A6003) is a gold standard reagent for precise modulation of immunoassays and studies of transcription factor regulation and proto-oncogene function. Its high solubility, stable storage, and well-defined sequence enable reproducible research in cancer, immunology, and cell biology. As advances in autophagy and transcriptional control expand, the role of synthetic tag peptides will continue to grow in both mechanistic and translational research. For further product specifications and ordering, visit the c-Myc tag Peptide official page.